How is clonus typically managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Clonus

Clonus management depends critically on the underlying etiology: when clonus occurs as a symptom of serotonin syndrome or drug toxicity, immediately discontinue the offending agent and administer benzodiazepines; for chronic clonus from upper motor neuron lesions (stroke, spinal cord injury, multiple sclerosis), initiate baclofen as first-line pharmacotherapy. 1, 2, 3

Acute Management: Drug-Induced Clonus

Serotonin Syndrome

When clonus presents with agitation, diaphoresis, tremor, or hyperreflexia in the context of serotonergic medication use, this represents a medical emergency requiring immediate intervention:

  • Discontinue all serotonergic agents immediately (SSRIs, TCAs, tramadol, amphetamines) 1, 2
  • Administer benzodiazepines as first-line treatment for neuromuscular symptoms, agitation, and tremor 1, 2
  • Provide IV fluids for dehydration and autonomic instability 2
  • Implement external cooling measures (cooling blankets) for hyperthermia; avoid antipyretics as they are ineffective since fever results from muscular hyperactivity rather than hypothalamic dysregulation 2
  • Avoid physical restraints as they exacerbate isometric contractions, worsening hyperthermia and lactic acidosis 4, 2

Critical pitfall: Serotonin syndrome has an 11% mortality rate and approximately 25% of patients require intubation and ICU admission, making rapid recognition essential 2. Clonus and hyperreflexia are highly diagnostic when occurring with serotonergic drug exposure 2.

Additional Pharmacotherapy for Severe Cases

  • Cyproheptadine (serotonin 2A antagonist): 12 mg orally initially, then 2 mg every 2 hours until symptom improvement, followed by maintenance of 8 mg every 6 hours 4, 2
  • Monitor for cyproheptadine side effects including sedation and hypotension 2

Chronic Management: Upper Motor Neuron Lesion-Related Clonus

For clonus resulting from stroke, spinal cord injury, multiple sclerosis, or other permanent descending motor neuron lesions:

First-Line Pharmacotherapy

  • Baclofen is the primary treatment for chronic clonus 3
  • Mechanism: GABA-B agonist that reduces spasticity and pathological stretch reflexes

Alternative Pharmacological Options

  • Cold application to the affected limb 3
  • Botulinum toxin injections for focal, disabling clonus 3, 5
  • Phenol injections for localized severe clonus 3

Antimyoclonic Agents for Severe Cases

When clonus is particularly disabling and refractory:

  • Levetiracetam is especially useful for posthypoxic myoclonus 5
  • Clonazepam has demonstrated efficacy for myoclonic movements 5
  • Valproate sodium can be effective as an antimyoclonic agent 4
  • Avoid phenytoin as it is typically ineffective for myoclonus and clonus 4

Important note: Combination therapy is often required to achieve adequate symptom control 5

Special Populations

Infants and Children

  • Evaluate for developmental delay and upper motor neuron dysfunction when clonus is detected, as 7.1% of infants with ankle clonus develop mental retardation and 1.2% have motor delay 6
  • Perform thorough neuromotor examination including postural tone, extremity tone, primitive reflexes, and antigravity movement 6
  • Consider measuring creatine phosphokinase (CK) and thyroid-stimulating hormone (TSH) if low tone with weakness is present 6
  • For startle-induced clonic attacks in infants with encephalopathy: myorelaxing drugs produce dramatic improvement, while antiepileptic drugs are typically unsuccessful 7

Patients with Encephalopathy

  • Myorelaxing drugs rather than antiepileptic drugs for severe, prolonged startle-induced clonic episodes 7
  • Video-EEG may be necessary to distinguish non-epileptic clonic attacks from true seizures 7

Monitoring for Complications

When managing acute drug-induced clonus (particularly serotonin syndrome):

  • Monitor for rhabdomyolysis with creatine kinase elevation 4, 2
  • Watch for metabolic acidosis 4, 2
  • Check for elevated transaminases 4, 2
  • Assess renal function for acute kidney injury 4, 2
  • Screen for disseminated intravascular coagulation 4, 2
  • Consider continuous EEG monitoring if seizures are suspected 4

Clinical Pearls

Mechanism understanding: Clonus represents involuntary, rhythmic muscle contractions at 5-8 Hz frequency, with ankle clonus oscillations occurring approximately every 160-200 ms 3. While traditionally attributed to hyperactive stretch reflexes from self-excitation, evidence suggests central generator activity interacting with peripheral events may contribute, as clonic EMG patterns occur across varied kinematic conditions and are not consistently related to muscle-tendon stretch 8.

Common mistake: Do not confuse clonus with epileptic seizures, particularly in children with encephalopathy where startle-induced clonic attacks can closely mimic clonic seizures but require entirely different management 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Serotonin Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clonus: definition, mechanism, treatment.

Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, 2015

Guideline

Manejo del Síndrome de Opsoclonus-Mioclonus Inducido por Fármacos

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Myoclonus.

Current opinion in neurology, 2003

Guideline

Clonus in Infants: Clinical Significance and Outcomes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.